Davion lists £30M bond in Vienna to fuel healthcare acquisition spree
What's the deal? Davion HealthcareDealroom has a profile for this one. Try Dealroom → has admitted a £30 million senior secured bond to trading on the Vienna MTF, operated by the Vienna Stock ExchangeDealroom has a profile for this one. Try Dealroom →. The five-year bond, issued through subsidiary Davion Healthcare Finance Ltd, carries a fixed annual coupon of 10.5% and commenced in August 2026.
What's the endgame? The Irish public company plans to deploy the proceeds acquisition-by-acquisition, targeting established, cash-generative businesses across medical devices, diagnostics, medical distribution, healthcare technology, and healthcare services. Security is granted over the assets bought with each tranche.
Why now? Davion says it has deals under review and wants capital ready. "The admission of our £30 million bond to the Vienna MTF gives Davion the capital to pursue the acquisition opportunities we are already evaluating across the healthcare sector," said chief executive officer Jack Kaye.
Kaye added the company is hunting for businesses that "can contribute earnings to the Group from day one," while promising discipline "about what we acquire and the price we pay."
What could go wrong? The company cautions that listing the bond does not confirm the full £30 million has been subscribed or funded. At a 10.5% coupon, the debt is not cheap, so returns depend on Davion buying earnings-accretive targets at the right price.
The signal: The raise sits in roughly the 91st percentile by size among all-time debt rounds in health, based on a sample of 5,743 deals. That places Davion's bond among the larger debt financings in the sector — a sign of appetite for buy-and-build strategies that use structured debt rather than equity to roll up cash-generative healthcare assets.
Image credit: roger4336
